Bihar Assembly Election 2025

Covid Vaccine: Bharat Biotech Gets DCGI Permission For Intranasal Booster Dose Trials

Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population

Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval

Govt Panel Recommends Regular Market Approval For Covishield And Covaxin

Receiving Reports That Children Being Administered Covid Jab Other Than Covaxin: Bharat Biotech

Covaxin Now A Universal Covid-19 Vaccine For Adults, Children: Bharat Biotech

Covaxin Booster Dose Shown To Neutralize Omicron, Delta Covid Variants: Bharat Biotech

Covaxin Booster Jabs Trial Shows 'Long-Term Safety With No Adverse Events': Bharat Biotech

No Paracetamol Or Painkillers Recommended After Being Vaccinated With Covaxin: Bharat Biotech

DCGI Gives Nod To Bharat Biotech's Intranasal Covid Vaccine For Phase 3 'Booster Dose Study'

‘False & Misleading’: Centre Dismisses Claims Of Expired COVID Vaccines Being Administered In India

Covaxin Showed Good Immune Response In Children, Slightly Better Than Adults: NTAGI Chief